BIONTECH

OpenCalais Metadata: Ticker

OpenCalais Metadata: LegalName

BioNTech AG

Türeci, Şahin recipient of top science award

Özlem Türeci and Uğur Şahin, the co-founders of BioNTech, and Katalin Kario, who also works at the Germany-based, biotechnology firm has been announced as the recipients of Germany's most prestigious medicine prize for their mRNA vaccine work.

They will receive the Paul Ehrlich and Ludwig Darmstaedter Prize 2022 on March 14.

Turkey plans to offer BioNTech booster shots starting November

Turkey is planning to offer a third dose of the Pfizer-BioNTech vaccines starting from October to people who have already had two shots of the jab.

The first doses of the Pfizer-BioNTech jab were administered in April and the second doses in June. According to plans under consideration, the third dose of the vaccine will start to be given in November.

Bulgaria Battlles Rapid Surge of Covid-19 Infections amid Strong Vaccine Opposition

ulgaria has introduced new anti-COVID restrictions as the country battles a rapid surge of infections due to the Delta variant.

The eastern Balkan country has one of the highest coronavirus death rates in the European Union since the start of the pandemic.

Despite this, Bulgarian citizens are the most hesitant in the bloc to get vaccinated against COVID-19.

Bulgaria will Finally give Vaccines against COVID-19 to North Macedonia

After former Prime Minister Boyko Borissov spoke about donating vaccines against COVID-19 in March and April, and the caretaker government continued talking in June decided on the donation in August, in September the procedure was completed by the Bulgarian institutions by a decision of the National Assembly on Wednesday (September 8).

Pfizer Vaccine Becomes First to Receive Full FDA Approval

The US Food and Drug Administration (FDA) has given its full approval to the use of the Pfizer / BioNTech vaccine in the United States. Although the vaccine has been given so far, this has only happened with an "emergency" authorization.

The two-dose vaccine has met "the high standard of safety, efficiency and quality of production," said acting FDA director Janet Woodstock.

Pages